share_log

加拿大皇家银行:维持Avid Bioservices(CDMO.US)评级,由优于大市调整至优于大市评级, 目标价由7.00美元调整至8.00美元。

Zhitong Finance ·  Apr 30 13:14

加拿大皇家银行:维持Avid Bioservices(CDMO.US)评级,由优于大市调整至优于大市评级, 目标价由7.00美元调整至8.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment